Expanding the therapeutic repertoire of infantile haemangiomas: Cohort-blinded study of oral nadolol compared with propranolol

British Journal of Dermatology

Volumn 168, Issue 1, 2013, Pages 222-224

  Pope, E ^a   Chakkittakandiyil, A ^a   Lara Corrales, I ^a   Maki, E ^b   Weinstein, M ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b Analitica Statistical Consulting Inc   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

NADOLOL; PROPRANOLOL;

CAPILLARY HEMANGIOMA; CLINICAL ARTICLE; COHORT ANALYSIS; COMMON COLD; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; FEASIBILITY STUDY; FEMALE; GASTROINTESTINAL SYMPTOM; HEART BEAT; HUMAN; INFANT; LETTER; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SINGLE BLIND PROCEDURE; SLEEP DISORDER; TREATMENT DURATION; WHEEZING;

ADMINISTRATION, ORAL; ADRENERGIC BETA-ANTAGONISTS; DRUG ADMINISTRATION SCHEDULE; FEASIBILITY STUDIES; FEMALE; HEAD AND NECK NEOPLASMS; HEMANGIOMA; HUMANS; INFANT; MALE; NADOLOL; PROPRANOLOL; TREATMENT OUTCOME;

EID: 84872871017     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2012.11131.x     Document Type: Letter

References (10)

1. Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, et al. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008; 358: 2649-51.
2. Sun H, Mao Y, Wang J, Ma Y,. Effects of beta-adrenergic antagonist, propranolol on spatial memory and exploratory behavior in mice. Neurosci Lett 2011; 498: 133-7.
3. Heel RC, Brogden RN, Pakes GE, et al. Nadolol: a review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris. Drugs 1980; 20: 1-23.
4. Lee RJ, Evans DB, Baky SH, Laffan RJ,. Pharmacology of nadolol (SQ 11725), a beta-adrenergic antagonist lacking direct myocardial depression. Eur J Pharmacol 1975; 33: 371-82.
5. Schiff AA, Saxey A,. Autoradiography of nadolol and propranolol in the rat. Xenobiotica 1984; 14: 687-91.
6. Mehta AV, Chidambaram B,. Efficacy and safety of intravenous and oral nadolol for supraventricular tachycardia in children. J Am Coll Cardiol 1992; 19: 630-5.
7. Connor DF, Ozbayrak KR, Benjamin S, et al. A pilot study of nadolol for overt aggression in developmentally delayed individuals. J Am Acad Child Adolesc Psychiatry 1997; 36: 826-34.
8. Pope E, Krafchik BR, Macarthur C, et al. Oral versus high-dose pulse corticosteroids for problematic infantile hemangiomas: a randomized, controlled trial. Pediatrics 2007; 119: e1239-47.
9. Pope E, Chakkittakandiyil A,. Topical timolol gel for infantile hemangiomas: a pilot study. Arch Dermatol 2010; 146: 564-5.
10. Mehta AV, Chidambaram B, Rice PJ,. Pharmacokinetics of nadolol in children with supraventricular tachycardia. J Clin Pharmacol 1992; 32: 1023-7.